Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
AZN LAWSUIT ALERT: The Gross Law Firm Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming Deadline
05:45am, Thursday, 30'th Jan 2025
NEW YORK , Jan. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN). Shareholders who purchased shares of AZN during the class peri
Shareholders that lost money on AstraZeneca PLC (AZN) should contact Levi & Korsinsky about pending Class Action - AZN
10:00pm, Wednesday, 29'th Jan 2025
NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securitie
February 21, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against AZN
09:30pm, Wednesday, 29'th Jan 2025
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities law
Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts
07:21pm, Wednesday, 29'th Jan 2025
The latest trading day saw Astrazeneca (AZN) settling at $70.25, representing a +0.95% change from its previous close.
Class Action Filed Against AstraZeneca PLC (AZN) - February 21, 2025 Deadline to Join - Contact Levi & Korsinsky
05:15pm, Wednesday, 29'th Jan 2025
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities law
AstraZeneca (AZN) Faces Securities Class Action After Reports of PRC Probe into Fraud and Corruption – Hagens Berman
04:41pm, Wednesday, 29'th Jan 2025
SAN FRANCISCO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- AstraZeneca (NASDAQ: AZN), the Anglo-Swedish pharmaceutical giant, has seen its stock price tumble 15 percent over the past six months, buffeted by a s
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca Lawsuit - AZN
04:15pm, Wednesday, 29'th Jan 2025
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities law
NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
Class Action Filed Against AstraZeneca PLC (AZN) - February 21, 2025 Deadline to Join – Contact The Gross Law Firm
12:44pm, Wednesday, 29'th Jan 2025
NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN).
Levi & Korsinsky Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming Deadline - AZN
12:30pm, Wednesday, 29'th Jan 2025
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities law
Should AstraZeneca Stock Be in Your Portfolio Pre-Q4 Earnings?
11:51am, Wednesday, 29'th Jan 2025
AZN's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected to have driven the company's top line.
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities law
The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against AstraZeneca PLC
11:00am, Wednesday, 29'th Jan 2025
LOS ANGELES, CA / ACCESS Newswire / January 29, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZe
Here's Why Astrazeneca (AZN) is a Strong Value Stock
10:46am, Wednesday, 29'th Jan 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
NEW YORK, NY / ACCESS Newswire / January 29, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ:AZN) between February 23, 2022 a
